{"id":39635,"date":"2026-01-28T22:26:24","date_gmt":"2026-01-28T21:26:24","guid":{"rendered":"https:\/\/europa-peptide.com\/?post_type=product&p=39635"},"modified":"2026-05-21T22:51:05","modified_gmt":"2026-05-21T20:51:05","slug":"pt-141-10-mg","status":"publish","type":"product","link":"https:\/\/europa-peptide.com\/sv\/shop\/pt-141-10mg\/","title":{"rendered":"PT-141 10 mg"},"content":{"rendered":"

PT-141 (Bremelanotide) - Peptid f\u00f6r modulering av melanokortinreceptor<\/strong><\/p>\n

Sammans\u00e4ttning:<\/strong> PT-141 (10 mg frystorkat peptidpulver)
Kategori:<\/strong> Peptid
Form:<\/strong> 10 mg injektionsflaska med frystorkat pulver
Administration:<\/strong> Subkutan forskningsapplikation efter rekonstitution med sterilt eller bakteriostatiskt vatten (beroende p\u00e5 studiedesign)<\/p>\n

\n

Vad \u00e4r PT-141?<\/h3>\n

PT-141, \u00e4ven k\u00e4nd som Bremelanotid<\/strong>, \u00e4r en syntetisk peptid som h\u00e4rr\u00f6r fr\u00e5n melanokortinanaloger och \u00e4r s\u00e4rskilt utformad f\u00f6r att interagera med melanokortinreceptorer (MC3R, MC4R)<\/strong> i det centrala nervsystemet.<\/p>\n

Till skillnad fr\u00e5n peptider som verkar genom hormonella eller vaskul\u00e4ra v\u00e4gar har PT-141 studerats f\u00f6r sin direkt aktivitet i centrala nervsystemet<\/strong>, s\u00e4rskilt med avseende p\u00e5 beteendem\u00e4ssiga och neuroendokrina signalmekanismer.<\/p>\n

I forskningssammanhang unders\u00f6ks PT-141 (10 mg) i stor utstr\u00e4ckning f\u00f6r sina effekter p\u00e5 centrala upphetsningsv\u00e4gar, motivationssignalering och melanokortinmedierad neurotransmission<\/strong>, vilket g\u00f6r det till en v\u00e4letablerad f\u00f6rening inom neurobiologi och beteendevetenskaplig forskning.<\/p>\n

\u27a1\ufe0f Idealisk f\u00f6r neuroendokrin forskning, studier av melanokortinreceptorer och CNS-signalering.<\/p>\n

\n

Viktiga forskningsresultat<\/h3>\n

Central melanokortinaktivering: Uppvisar h\u00f6g affinitet f\u00f6r MC3R- och MC4R-receptorer.<\/p>\n

Modulering av neurotransmittorv\u00e4gar: P\u00e5verkar central signalering som \u00e4r involverad i motivation och upphetsningsrelaterade beteenden.<\/p>\n

Icke-hormonell mekanism: F\u00f6rlitar sig inte p\u00e5 direkt hormonell modulering eller perifera vasodilateringsv\u00e4gar.<\/p>\n

Snabb CNS aktivitetsprofil: Visar snabb start av \u00e5tg\u00e4rder i experimentella forskningsmodeller.<\/p>\n

Stort forskningsintresse: Omfattande studier inom neurobiologi, beteendevetenskap och receptorfarmakologi.<\/p>\n

\n

Verkningsmekanism<\/h3>\n

PT-141 verkar genom att aktivera melanokortinreceptorer i det centrala nervsystemet, vilket leder till<\/p>\n

Stimulering av melanokortinreceptorer \u2192 Aktivering av MC3R- och MC4R-v\u00e4garna<\/p>\n

Modulering av centrala neurotransmittorer \u2192 F\u00f6r\u00e4ndrad signalering i motivations- och upphetsningskretsar<\/p>\n

CNS-fokuserad aktivitet \u2192 Prim\u00e4ra effekter som f\u00f6rmedlas centralt snarare \u00e4n perifert<\/p>\n

Receptorspecifik verkningsprofil \u2192 Riktad interaktion utan direkt inblandning av hormonella v\u00e4gar<\/p>\n

\n

Dosering och anv\u00e4ndning<\/h3>\n

Rekonstituera med sterilt eller bakteriostatiskt vatten f\u00f6re anv\u00e4ndning.<\/p>\n

Typiska forskningsinriktningar beror p\u00e5 experimentell utformning och protokollkrav.
En injektionsflaska med 10 mg \u00e4r l\u00e4mplig f\u00f6r flera forskningsapplikationer, dos-responsstudier eller ut\u00f6kade experimentella protokoll.<\/p>\n

F\u00f6rvara den rekonstituerade l\u00f6sningen i kylsk\u00e5p och anv\u00e4nd den inom 2-3 veckor.<\/p>\n

\n

Instruktioner f\u00f6r f\u00f6rvaring<\/h3>\n

F\u00f6rvaras vid 2-8 \u00b0C (36-46 \u00b0F)
Skyddar mot ljus och fukt
F\u00e5r inte frysas
Anv\u00e4nd den rekonstituerade l\u00f6sningen inom 2-3 veckor<\/p>\n

\n

Varf\u00f6r v\u00e4lja PT-141 (10 mg)?<\/h3>\n

PT-141 \u00e4r uppskattad f\u00f6r sin unik central verkningsmekanism<\/strong> som riktar sig mot melanocortinreceptorer snarare \u00e4n perifera eller hormonella system.
Detta g\u00f6r den s\u00e4rskilt relevant f\u00f6r avancerad forskning inom CNS-signalering, receptorfarmakologi och neurobeteendem\u00e4ssiga v\u00e4gar<\/strong>.<\/p>\n

Den \u00e4r allm\u00e4nt respekterad inom vetenskaplig forskning f\u00f6r sin receptorspecificitet, centrala aktivitetsprofil och starka relevans f\u00f6r melanocortinbaserade unders\u00f6kningar.<\/p>\n

Best\u00e4ll PT-141 (10 mg)<\/strong> och utforska dess potential inom avancerad melanocortinreceptorforskning, CNS-signalstudier och neuroendokrina unders\u00f6kningar.<\/p>","protected":false},"excerpt":{"rendered":"

PT-141 (Bremelanotide) \u2013 Melanocortin Receptor Modulation Peptide Composition: PT-141 (10 mg lyophilized peptide powder)Category: PeptideForm: 10 mg vial with freeze-dried powderAdministration: Subcutaneous research application after reconstitution with sterile or bacteriostatic water (depending on study design) What is PT-141? PT-141, also known as Bremelanotide, is a synthetic peptide derived from melanocortin analogues and is specifically designed to interact with melanocortin receptors (MC3R, MC4R) in the central nervous system. Unlike peptides that act through hormonal or vascular pathways, PT-141 has been studied for its direct central nervous system activity, particularly in relation to behavioral and neuroendocrine signaling mechanisms. In research settings, PT-141 (10 mg) is widely investigated for its effects on central arousal pathways, motivational signaling, and melanocortin-mediated neurotransmission, making it a well-established compound in neurobiology and behavioral science research. \u27a1\ufe0f Ideal for neuroendocrine research, melanocortin receptor studies, and CNS signaling investigations. Key Research Findings Central Melanocortin Activation: Demonstrates high affinity for MC3R and MC4R receptors. Neurotransmitter Pathway Modulation: Influences central signaling involved in motivation and arousal-related behaviors. Non-Hormonal Mechanism: Does not rely on direct hormonal modulation or peripheral vasodilation pathways. Rapid CNS Activity Profile: Shows fast onset of action in experimental research models. High Research Interest: Extensively studied in neurobiology, behavioral science, and receptor pharmacology. Mechanism of Action PT-141 acts by activating melanocortin receptors in the central nervous system, leading to: Melanocortin Receptor Stimulation \u2192 Activation of MC3R and MC4R pathways Central Neurotransmitter Modulation \u2192 Altered signaling in motivation and arousal circuits CNS-Focused Activity \u2192 Primary effects mediated centrally rather than peripherally Receptor-Specific Action Profile \u2192 Targeted interaction without direct hormonal pathway involvement Dosage & Application Reconstitute with sterile or bacteriostatic water before use. Typical research concentrations depend on experimental design and protocol requirements.A 10 mg vial is suitable for multiple research applications, dose-response studies, or extended experimental protocols. Store the reconstituted solution refrigerated and use within 2\u20133 weeks. Storage Instructions Store at 2\u20138 \u00b0C (36\u201346 \u00b0F)Protect from light and moistureDo not freezeUse reconstituted solution within 2\u20133 weeks Why Choose PT-141 (10 mg)? PT-141 is valued for its unique central mechanism of action targeting melanocortin receptors rather than peripheral or hormonal systems.This makes it especially relevant for advanced research into CNS signaling, receptor pharmacology, and neurobehavioral pathways. It is widely respected in scientific research for its receptor specificity, central activity profile, and strong relevance to melanocortin-based investigations. Order PT-141 (10 mg) and explore its potential in advanced melanocortin receptor research, CNS signaling studies, and neuroendocrine investigations.<\/p>","protected":false},"featured_media":39641,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[17,26,27],"product_tag":[],"class_list":["post-39635","product","type-product","status-publish","has-post-thumbnail","product_cat-all-products","product_cat-neuroandvascularprotection","product_cat-peptidesandresearchdrugs","entry","has-media","first","instock","shipping-taxable","purchasable","product-type-simple"],"acf":[],"aioseo_notices":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/product\/39635","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/comments?post=39635"}],"version-history":[{"count":2,"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/product\/39635\/revisions"}],"predecessor-version":[{"id":47637,"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/product\/39635\/revisions\/47637"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/media\/39641"}],"wp:attachment":[{"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/media?parent=39635"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/product_brand?post=39635"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/product_cat?post=39635"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/europa-peptide.com\/sv\/wp-json\/wp\/v2\/product_tag?post=39635"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}